# Imuran Dosing in Crohn's Disease Study

> **NCT00113503** · PHASE2 · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 50 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Azathioprine weight-based dose
- **DRUG:** Azathioprine individualised dose

## Key facts

- **NCT ID:** NCT00113503
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Insufficient enrollment
- **Last updated:** 2017-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113503, "Imuran Dosing in Crohn's Disease Study". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00113503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*